CE2 HEALTH ECONOMIC ASSESSMENT OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61604-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61604-X/fulltext
Title :
CE2 HEALTH ECONOMIC ASSESSMENT OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61604-X&doi=10.1016/S1098-3015(10)61604-X
First page :
Section Title :
Open access? :
No
Section Order :
51